5 The introduction of capsule endoscopy represented a major advance in the diagnosis of small bowel diseases, such as in the presented case. FL is localized in the bowel and regional lymph Dabrafenib molecular weight nodes in the vast majority of cases. The prognosis is favorable even when the disease is disseminated.3 The authors declare that no experiments were
performed on humans or animals for this study. The authors declare that they have followed the protocols of their work center on the publication of patient data and that all the patients included in the study received sufficient information and gave their written informed consent to participate in the study. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document. The authors have no conflicts of interest to declare. “
“A 58-year-old woman was referred to our Gastroenterology Clinic for long-lasting history of heartburn, chest pain and regurgitation. Her past medical history was notable for major depressive disorder and essential hypertension. She was under pantoprazole qd, valsartan and hydrochlorothiazide. During the two previous years, she had been submitted to two upper digestive endoscopies which
described a severe reflux esophagitis and a “papyraceous” esophagus in the lower third of the esophagus. In the absence of clinical response check details the pantoprazole dose was increased. She stopped the antihypertensive drug and started limiting her diet to mashed food. As symptoms progressed to mixed (solid and liquid) dysphagia and odynophagia we performed an upper digestive endoscopy. It revealed white membranes with vertical fissures adjacent 3-oxoacyl-(acyl-carrier-protein) reductase to normal appearing mucosa in the distal esophagus (Fig.
1). These membranes were easily detached and exposed a normal appearing mucosa (Fig. 2). Biopsies showed mild chronic esophagitis, sloughed layers of squamous epithelium with parakeratosis and no microorganisms, namely fungi (Fig. 3). Correlating the endoscopic and histologic findings the diagnosis made was esophagitis dissecans superficialis (EDS). EDS was first described in 1892 and it is a rare, probably under-recognized and underreported, entity.1 and 2 It has been associated with drinking hot beverages, medications (bisphosphonates and nonsteroidal anti-inflammatory drugs), heavy smoking, achalasia, skin conditions (prurigo nodularis and bullous dermatoses), esophageal iatrogenic injury (variceal sclerotherapy and band ligation, esophageal dilation and mediastinal radiation for lung cancer), celiac disease, immunosuppression and impaired mobility.2, 3 and 4 Nevertheless, EDS has been found in the absence of obvious predisposing conditions, as was the case in our patient.